WO2001075167A1 - Strategie genetique inverse pour identifier des mutations fonctionnelles dans des genes de sequence connue - Google Patents
Strategie genetique inverse pour identifier des mutations fonctionnelles dans des genes de sequence connue Download PDFInfo
- Publication number
- WO2001075167A1 WO2001075167A1 PCT/US2001/010545 US0110545W WO0175167A1 WO 2001075167 A1 WO2001075167 A1 WO 2001075167A1 US 0110545 W US0110545 W US 0110545W WO 0175167 A1 WO0175167 A1 WO 0175167A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mutations
- mutation
- endonuclease
- gene
- organism
- Prior art date
Links
- 230000035772 mutation Effects 0.000 title claims abstract description 210
- 108090000623 proteins and genes Proteins 0.000 title claims description 81
- 230000002068 genetic effect Effects 0.000 title abstract description 21
- 230000002441 reversible effect Effects 0.000 title abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 146
- 108020004414 DNA Proteins 0.000 claims abstract description 61
- 238000001514 detection method Methods 0.000 claims abstract description 39
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 37
- 230000003321 amplification Effects 0.000 claims abstract description 36
- 239000003471 mutagenic agent Substances 0.000 claims abstract description 20
- 231100000707 mutagenic chemical Toxicity 0.000 claims abstract description 20
- 230000003505 mutagenic effect Effects 0.000 claims abstract description 17
- 241000196324 Embryophyta Species 0.000 claims description 65
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 claims description 29
- 238000004458 analytical method Methods 0.000 claims description 29
- 239000012634 fragment Substances 0.000 claims description 29
- 241000219194 Arabidopsis Species 0.000 claims description 26
- 108010042407 Endonucleases Proteins 0.000 claims description 26
- 102000004533 Endonucleases Human genes 0.000 claims description 26
- 238000003776 cleavage reaction Methods 0.000 claims description 23
- 230000007017 scission Effects 0.000 claims description 22
- 108091027305 Heteroduplex Proteins 0.000 claims description 20
- 230000007704 transition Effects 0.000 claims description 18
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 claims description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 10
- 230000005855 radiation Effects 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 8
- 239000002962 chemical mutagen Substances 0.000 claims description 8
- LNCCBHFAHILMCT-UHFFFAOYSA-N 2-n,4-n,6-n-triethyl-1,3,5-triazine-2,4,6-triamine Chemical compound CCNC1=NC(NCC)=NC(NCC)=N1 LNCCBHFAHILMCT-UHFFFAOYSA-N 0.000 claims description 7
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 claims description 7
- FUSGACRLAFQQRL-UHFFFAOYSA-N N-Ethyl-N-nitrosourea Chemical compound CCN(N=O)C(N)=O FUSGACRLAFQQRL-UHFFFAOYSA-N 0.000 claims description 7
- 101710163270 Nuclease Proteins 0.000 claims description 7
- 238000001502 gel electrophoresis Methods 0.000 claims description 7
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 claims description 7
- HEGWNIMGIDYRAU-UHFFFAOYSA-N 3-hexyl-2,4-dioxabicyclo[1.1.0]butane Chemical group O1C2OC21CCCCCC HEGWNIMGIDYRAU-UHFFFAOYSA-N 0.000 claims description 6
- ARSRBNBHOADGJU-UHFFFAOYSA-N 7,12-dimethyltetraphene Chemical compound C1=CC2=CC=CC=C2C2=C1C(C)=C(C=CC=C1)C1=C2C ARSRBNBHOADGJU-UHFFFAOYSA-N 0.000 claims description 6
- ZRKWMRDKSOPRRS-UHFFFAOYSA-N N-Methyl-N-nitrosourea Chemical compound O=NN(C)C(N)=O ZRKWMRDKSOPRRS-UHFFFAOYSA-N 0.000 claims description 6
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 5
- 238000005251 capillar electrophoresis Methods 0.000 claims description 5
- -1 dimethylnitosamine Chemical compound 0.000 claims description 5
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 5
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 4
- ZFIVKAOQEXOYFY-UHFFFAOYSA-N Diepoxybutane Chemical compound C1OC1C1OC1 ZFIVKAOQEXOYFY-UHFFFAOYSA-N 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 241000219146 Gossypium Species 0.000 claims description 4
- 240000005979 Hordeum vulgare Species 0.000 claims description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 4
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 4
- 108020004485 Nonsense Codon Proteins 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 4
- 241000018646 Pinus brutia Species 0.000 claims description 4
- 235000011613 Pinus brutia Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000021374 legumes Nutrition 0.000 claims description 4
- 235000009973 maize Nutrition 0.000 claims description 4
- 230000037434 nonsense mutation Effects 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 244000241257 Cucumis melo Species 0.000 claims description 3
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 3
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims description 3
- 241000252212 Danio rerio Species 0.000 claims description 3
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims description 3
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims description 3
- 241000701832 Enterobacteria phage T3 Species 0.000 claims description 3
- 241000701533 Escherichia virus T4 Species 0.000 claims description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 3
- PWGOWIIEVDAYTC-UHFFFAOYSA-N ICR-170 Chemical compound Cl.Cl.C1=C(OC)C=C2C(NCCCN(CCCl)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 PWGOWIIEVDAYTC-UHFFFAOYSA-N 0.000 claims description 3
- 108010086093 Mung Bean Nuclease Proteins 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 239000013043 chemical agent Substances 0.000 claims description 3
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 claims description 3
- 229960004630 chlorambucil Drugs 0.000 claims description 3
- 229960004397 cyclophosphamide Drugs 0.000 claims description 3
- 239000003398 denaturant Substances 0.000 claims description 3
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 claims description 3
- 229940008406 diethyl sulfate Drugs 0.000 claims description 3
- 108010064144 endodeoxyribonuclease VII Proteins 0.000 claims description 3
- 229960004961 mechlorethamine Drugs 0.000 claims description 3
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 claims description 3
- 229960001924 melphalan Drugs 0.000 claims description 3
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 claims description 3
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 claims description 3
- 229960000624 procarbazine Drugs 0.000 claims description 3
- JETDZFFCRPFPDH-UHFFFAOYSA-N quinacrine mustard dihydrochloride Chemical compound [H+].[H+].[Cl-].[Cl-].C1=C(Cl)C=CC2=C(NC(C)CCCN(CCCl)CCCl)C3=CC(OC)=CC=C3N=C21 JETDZFFCRPFPDH-UHFFFAOYSA-N 0.000 claims description 3
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims description 3
- 229960004528 vincristine Drugs 0.000 claims description 3
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims description 3
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 6
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical group O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims 4
- 241000244202 Caenorhabditis Species 0.000 claims 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims 2
- 240000004658 Medicago sativa Species 0.000 claims 2
- 240000003768 Solanum lycopersicum Species 0.000 claims 2
- 241000209140 Triticum Species 0.000 claims 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims 2
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 claims 2
- 238000012300 Sequence Analysis Methods 0.000 claims 1
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 claims 1
- 239000011544 gradient gel Substances 0.000 claims 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims 1
- 238000012216 screening Methods 0.000 abstract description 28
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 7
- 239000000047 product Substances 0.000 description 45
- 238000012225 targeting induced local lesions in genomes Methods 0.000 description 39
- 238000003752 polymerase chain reaction Methods 0.000 description 37
- 231100000350 mutagenesis Toxicity 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 24
- 101710083873 DNA (cytosine-5)-methyltransferase CMT2 Proteins 0.000 description 20
- 101710083875 DNA (cytosine-5)-methyltransferase CMT3 Proteins 0.000 description 18
- 238000002703 mutagenesis Methods 0.000 description 18
- 108020004705 Codon Proteins 0.000 description 16
- 239000000499 gel Substances 0.000 description 16
- 230000006870 function Effects 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 11
- 108700028369 Alleles Proteins 0.000 description 10
- 108010087726 chromomethylase Proteins 0.000 description 10
- 230000003902 lesion Effects 0.000 description 10
- 150000007523 nucleic acids Chemical class 0.000 description 9
- 238000012163 sequencing technique Methods 0.000 description 9
- 241000219195 Arabidopsis thaliana Species 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 238000011176 pooling Methods 0.000 description 7
- 230000002939 deleterious effect Effects 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 210000004602 germ cell Anatomy 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 241000255925 Diptera Species 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000000137 annealing Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 102000054765 polymorphisms of proteins Human genes 0.000 description 5
- 238000003757 reverse transcription PCR Methods 0.000 description 5
- 108010077544 Chromatin Proteins 0.000 description 4
- 108050005811 Chromo domains Proteins 0.000 description 4
- 102000017589 Chromo domains Human genes 0.000 description 4
- 238000001712 DNA sequencing Methods 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 244000038559 crop plants Species 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000000869 mutational effect Effects 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 108020005544 Antisense RNA Proteins 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 108060004795 Methyltransferase Proteins 0.000 description 3
- 102000016397 Methyltransferase Human genes 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 210000003483 chromatin Anatomy 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000003184 complementary RNA Substances 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000010230 functional analysis Methods 0.000 description 3
- 230000013011 mating Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000219823 Medicago Species 0.000 description 2
- 241000219828 Medicago truncatula Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 101100365805 Plasmodium falciparum (isolate 3D7) Sir2B gene Proteins 0.000 description 2
- 108091030071 RNAI Proteins 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 101150113876 Sir2B gene Proteins 0.000 description 2
- 241000255588 Tephritidae Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000037429 base substitution Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 238000002743 insertional mutagenesis Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000017448 oviposition Effects 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000007862 touchdown PCR Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 208000035669 Autosomal dominant Charcot-Marie-Tooth disease type 2B Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 101100221122 Caenorhabditis elegans cmt-1 gene Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 201000008973 Charcot-Marie-Tooth disease type 2B Diseases 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101000584785 Homo sapiens Ras-related protein Rab-7a Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 108020005120 Plant DNA Proteins 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 102100030019 Ras-related protein Rab-7a Human genes 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- KVHISFJMQMSZHQ-UHFFFAOYSA-N acridin-10-ium;chloride;hydrochloride Chemical compound Cl.[Cl-].C1=CC=CC2=CC3=CC=CC=C3[NH+]=C21 KVHISFJMQMSZHQ-UHFFFAOYSA-N 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000004182 chemical digestion Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000003936 denaturing gel electrophoresis Methods 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 230000002616 endonucleolytic effect Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001157 hypermorphic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 101150112095 map gene Proteins 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 238000009401 outcrossing Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 230000037432 silent mutation Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000037436 splice-site mutation Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Definitions
- sequence comparison tools that detect protein sequence similarity to previously studied genes often allow a related function to be inferred.
- the present invention provides a reverse genetic strategy that combines the high density of mutations offered by traditional mutagenesis methods with rapid mutational screening to discover induced lesions.
- the method designated TILLING (Targeting Induced Local Lesions In Genomes)
- TILLING Targeting Induced Local Lesions In Genomes
- mutagenesis methods e.g., chemical-induced (for example, using ethyl methanesulfonate (EMS)(Koornneef et al., Mutat. Res. 93:109-123 (1982))
- EMS ethyl methanesulfonate
- mutation analysis tools such as the detection of single base pair changes by heteroduplex analysis (Underhill et al., Genome Res.
- the TILLING method generates a wide range of mutant alleles, is fast and automatable, and is applicable to any organism that can be mutagenized, stored and propagated.
- the present invention provides a reverse genetic method for identifying functional mutations in a gene of known sequence comprising treating an organism or cell with mutagen which induces mutations in the DNA of an organism or cell; preparing isolated genomic DNA from the mutagenized organism or cell; amplifying a region of a gene of known sequence; and screening for mutations in the mutagenized DNA sequence in the gene as compared to the same sequence of the gene in the wild type parent organism or cell.
- the method designated TILLING for Targeted Induced Local Lesion in Genomes, combines the high density of mutations provided by traditional mutagenesis methods with rapid mutational analysis methods to identify mutations of interest in genes of known sequence without inserting heterologous nucleic acids into an organism or cell.
- Methods for mutagenizing the genome of an organism or a cell to induce mutations can include treating an organism or cell with chemical agents or radiation.
- a traditional chemical mutagen such as ethyl methanesulfonate, methylmethane sulfonate, N-ethyl-N-nitrosourea, triethylmelamine, diepoxyalkanes (diepoxyoctane, diepoxybutane, and the like), 2-methoxy-6-chloro-9[3-(ethyl-2-chloro-ethyl) aminopropylamino] acridine dihydrochloride, formaldehyde, and the like can be used.
- Nucleic acid amplification methods suitable for use in the methods of the present invention include, but are not limited to PCR methods such as RT-PCR. Primers are selected to amplify a region of the genome comprising the gene of interest. The PCR product is then analyzed for the presence of mutations. Mutations can be detected, for example, by single-stranded conformational polymorphism or by heteroduplex analysis, and the like.
- Methods for heteroduplex analysis compatible with the methods of the present invention include constant denaturant capillary electrophoresis, denaturing high pressure liquid chromatography, and enzyme or chemical digestion of nucleotide mismatches followed by separation and detection of the digested DNA.
- Each of these methods have been used previously to identify naturally occurring polymorphisms consisting of single base changes in genes of interest (Cotton et al., Mutation Detection: A Practical Approach, IRL Press, Oxford, England (1998)).
- TILLING the mutations detected are either missense or nonsense mutations which result in altered or truncated protein products.
- the organisms or cells analyzed by the disclosed methods can be either homozygous or heterozygous for the mutation of interest.
- the methods of the present invention are applicable to any organism which can be heavily mutagenized, including both plants and animals.
- TILLING has been applied to two Arabidopsis thaliana chromomethylase genes related to CMT 1, a DNA methyltransferase homologue with a chromodomain (Henikoff and Comai, Genetics 149:307-318 (1998)).
- the methods are also applicable to other plants, particularly crop plants such as maize, alfalfa, wheat, barley, soy beans, cotton, pine, rice, legumes, i.e., Medicago truncatula, and the like.
- Using the methods of the present invention it is possible to select for plants with phenotypic variations of commercial interest without introducing foreign DNA of any type into the plant genome.
- Figure 1 depicts in the form of a cartoon the TILLING strategy applied to a plant such as Arabidopsis thaliana.
- Figure 2 depicts the structure of Arabidopsis thaliana chromomethylase genes. Exons are shown as boxes with cytosine DNA methyltransferase blocks (black rectangles) and chromodomain blocks (gray rectangles) indicated. Fragments used for TILLING analysis are indicated as horizontal lines above CMT2 and below CMT3.
- Figure 3 provides a depiction of dHPLC chromatograms showing typical sensitivity for detection of a transition mutation on a PCR fragment, where Ler and Col templates, which differ by a single C/G to T/A change, have been mixed in the indicated ratios and amplified. Retention time on the dHPLC column is plotted against intensity of the signal in millivolts (mV).
- Figure 4 depicts the sites that are most susceptible to base transition mutations after treatment with EMS for the CMT3B fragment (the nucleotide sequence of the fragment is depicted as SEQ ID NO: 11, and the amino acids encoded by the wild-type sequence and the mutations detected for each amino acid position for this fragment are depicted as SEQ ID NO: 12 and SEQ ID NO: 13).
- the position of Q479 to stop obtained in the screen is depicted as ⁇ (See Table 1).
- Figure 5 depicts in the form of a cartoon the high throughput TILLING strategy applied to a plant such as Arabidopsis thaliana as demonstrated in Example 3.
- the subject invention relates to methods for finding multiple mutations in genes of known sequence by combining mutagenesis with methods for finding point mutations.
- the present invention provides a method for the creation and subsequent detection of mutations within a selected (desired) DNA region.
- the mutations created provide a range of allele types, including knockouts and missense mutations, which will be useful in a variety of gene function and interaction studies. This method is particularly useful for studies in organisms that do not have extensive genetic tools or genomic DNA sequence available.
- Arabidopsis is mutagenized to produce a plurality of different point mutations and screened with semi-automated nucleic acid amplification-based methods, i.e., PCR, within a gene region of interest.
- mutations in any gene contained in the genome of Arabidopsis can be screened by the methods of the present invention in as few as a set of approximately 5-10,000 reference plants. It is expected that most phenotypes can be scored in the F2 progeny of reference plants, and therefore functional analysis can be easily performed.
- TILLING has been specifically applied to Arabidopsis and Drosophila
- the methods as described are of general use. Therefore, any organism that can be mutagenized can be TILLed, although plants are especially suitable.
- the general applicability of the methods of the present invention means that organisms lacking well-developed genetic tools can be TILLed. For example, but not by way of limitation, plants such as maize, alfalfa, barley, rice, soy beans, cotton, pine, melons, and other commercially important crop plants can be analyzed with the methods of the present invention. Additionally, model plant systems, such as the legume Medicago truncatula, can be examined using the methods of the present invention.
- seeds, pollen, germ cells and cells cultured from plants are suitable subjects for TILLING.
- animals are also suitable subject for TILLING.
- germ cells of animals such as nematodes, fruit flies, mice, chickens, turkeys, dogs, cats, cows, sheep, horses, pigs and other commercially important agricultural and companion animals can be analyzed with the methods of the instant invention.
- TILLING is related to a method whereby chemically mutagenized Caenorhabditis elegans cultured in microtiter plates were screened by PCR for deletions (Liu et al., Genome Res. 9:859-867 (1999)).
- this method requires screening of approximately 10 6 genomes (about 100 times more than that required for TILLING) to obtain a knock-out mutation, it is not likely to be generally applicable.
- several advantages over previously disclosed reverse genetic methods are realized including, for example:
- genomic DNAs are prepared and arrayed, the process is almost fully automated. All subsequent steps, including, for example, detection of mutations, e.g., by PCR and dHPLC analysis, can typically be performed in, for example, microtiter plates, which can be handled robotically.
- Chemical mutagens in particular, mutagens which result in primarily point mutations and short deletions, insertions, transversions, and or transitions (about 1 to about 5 nucleotides), such as ethyl methanesulfonate (EMS), methylmethane sulfonate (MMS), N-ethyl-N-nitrosourea (ENU), triethylmelamine (TEM), N-methyl-N-nitrosourea (MNU), procarbazine, chlorambucil, cyclophosphamide, diethyl sulfate, acrylamide monomer, melphalan, nitrogen mustard, vincristine, dimethylnitosamine, N-methyl-N'- nitro-Nitrosoguanidine (MNNG), nitrosoguanidine, 2-aminopurine, 7, 12 dimethyl- benz(a)anthracene (DMBA), ethylene oxide, hexamethylphosphoramide, bisulfan
- missense mutations not just knock-outs.
- temperature-sensitive missense alleles expected to be especially useful for gene interaction studies (Bowman et al, Plant Cell 1:37-52 (1989)), can be obtained.
- a PCR product useful for detection by, for example, dHPLC or gel electrophoresis following cleavage of an oligonucleotide strand at the position of a base mismatch, for example, by endonuclease digestion is the size of a small gene, small targets that are likely to be missed by other methods, such as, high density transposon tagging strategies or large DNA detection strategies (Wisman et al., Plant Mol. Biol. 37:989-999 (1998)); Bevan et al., Bioessays 21:110-120 (1999) each incorporated herein by reference) present no special problem for TILLING.
- Any gene can be targeted, whether essential or not, because mutations are detectable in both homozygotes, or heterozygotes.
- the methods of the present invention permits one to find mutations in a gene of interest in the absence of an assayable phenotype which may later be discerned, for example mutations that are present as a heterozygous mutation may not be detected in a heterozygote, but may be detectable when the identified mutations crossed and a homozygous individual is obtained.
- the concentration of the mutagen selected will be that which will induce a plurality of different mutations in the genome of the organism of interest.
- Mutagenesis refers to methods for inducing a plurality of mutations in the DNA of a cell.
- the mutations typically useful in the methods of the present invention are those which induce changes that alter or eliminate the function if the gene product (i.e., a nucleotide substitution, deletion, or insertion).
- the methods of the present invention are especially useful in detecting point mutations.
- Point mutations include single base transitions, base tranversions, insertions and deletions.
- the mutagenesis comprises exposing a germ cell of an organism, a cell, or a seed with a chemical mutagen, i.e., but not limited to those listed above.
- the cells can also be treated with, for example, radiation, i.e., x-rays and gamma-radiation, which induce primarily larger lesions, ultra-violet light, and the like.
- radiation i.e., x-rays and gamma-radiation
- a polynucleotide sequence encoding certain heterologous enzymes which can induce mutations i.e., a phyophosphohydrolase, such as the bacterial MutT gene which makes AT to CG transversions, and the like, can be introduced into the cell or seed.
- Appropriate mutation rates for mutagens will typically be in the range of about 1 mutation per 500 kilobase pairs (kbp) to about 1 mutation per 10 kbp.
- Genomic DNA is obtained from the selected F2 individuals and pooled. The pooled DNA is subjected to TILLING as described below using primers designed for one, or typically multiple (usually up to at least 12) marker regions or other regions of interest. The mutation rate at a particular region or gene locus can thus be determined by dividing the number of mutations found in all regions by the total number of base pairs screened.
- EMS was used to induce primarily point mutations in Arabidopsis.
- Other agents are well known to the skilled artisan which provide similar results in various other organisms as provided hereinabove.
- PCR polymerase chain reaction
- SSCP single-stranded conformational polymorphism
- Primers used for amplification are designed to specific regions of genes of interest.
- primers were designed with melting temperatures of 60°-70°C, and final annealing temperatures of T m -5°C are chosen.
- Amplification products are denatured and reannealed under conditions permitting heteroduplexes to form. Such denaturation and annealing can be carried out in a separate step from the amplification or can be incorporated into the amplification protocol.
- heteroduplexes can be fragmented by chemical cleavage.
- Chemical cleavage can be carried out by, for example, hydroxylamine and osmium tetroxide to react with the mismatch in a DNA heteroduplex.
- subsequent treatment with piperidine cleaves the mismatched strand at the point of the mismatch. Mutations are detected by the separation of the fragments and the identification of fragments smaller than the untreated heteroduplex.
- Heteroduplexes are also detectable by electrophoresis, for example by constant denaturant capillary electrophoresis (CDCE), or by denaturing high pressure liquid chromatography (dHPLC).
- DCE constant denaturant capillary electrophoresis
- dHPLC denaturing high pressure liquid chromatography
- dHPLC was chosen for the screening of mutation because it combines automation, speed of analysis and high overall detection sensitivity for unknown single base changes in a commercially available instrument.
- endonuclease cleavage was used to identify mutations because it is a reliable and inexpensive point mutation discovery method that can be performed even more rapidly than dHPLC and in a robust manner.
- Running time for dHPLC may limit throughput for the methods of the present invention, requiring about a week of screening for each mutation detected.
- the use of fluorescence detection rather than UV absorbance is expected to allow an order-of-magnitude increase in the number of genomes in a pool; smaller sample loads should minimize band broadening, allowing for better separation of heteroduplexes from homoduplexes.
- Fluorescence detection also may allow for multiplexing based on different fluorochromes, further increasing dHPLC throughput.
- fluorescence multiplexing is not yet commercially available for dHPLC, multiplexing has been performed by co-amplifying fragments that are differentially retained on the column but have similar melting temperatures.
- Heteroduplexes can be detected enzymatically, for example using an endonuclease that recognizes and cleaves at mismatches in a heteroduplex.
- Suitable endonucleases for use in the instant methods include resolvases, RNases, bacteriophage T4 endonuclease VII, bacteriophage T7, endonuclease I, Saccharomyces cerevisiae endonuclease XI, Saccharomyces cerevisiae endonuclease X2, Saccharomyces cerevisiae endonuclease X3, SI nuclease, CEL I, PI nuclease, or mung bean nuclease.
- the CEL I endonuclease (Oleykowski et al., Nucl. Acids Res. 26:4597-4602 (1998)) is used to cleave heteroduplex mismatches.
- CEL I a plant-specific extracellular glycoprotein that belongs to the SI nuclease family (Oleykowski et al., ibid.), has been shown to be suitable for genotyping applications because it preferentially cleaves mismatches of all types (Oleykowski et al., ibid.) and has been used to detect heterozygous polymorphisms in DNA pools (Kulinski et al., Biotechniques 29: 44-46 (2000)).
- mutations are identified using a high-throughput TILLING method that utilizes an endonuclease to cleave heteroduplex mismatches.
- mutagenized DNA is first amplified using primers specific for a gene region of interest.
- the primers are preferably labeled with different independently detectable labels. This differential double-end labeling of amplification products allows for rapid visual confirmation, because mutations are detected on complementary strands, and so can be easily distinguished from amplification artifacts.
- the choice of labels useful in the methods of the present invention will be evident to the skilled artisan.
- Independent detection can be accomplished by, for example, using fluorochrome labels, i.e., fiuorescein isothiocyanate (FITC), terachlorofluorescem, hexachlorofluoroscem, Cy3, Cy5, Texas Red, infrared dyes (IRDYE 700, IRDYE 770, IRDYE 800), or APC, and the like, that fluoresce at different wavelengths permitting clear identification of each label by its particular wavelength, or by selecting radioactive labels that are detectable using different filters.
- FITC fiuorescein isothiocyanate
- terachlorofluorescem terachlorofluorescem
- hexachlorofluoroscem Cy3, Cy5, Texas Red
- infrared dyes IRDYE 700, IRDYE 770, IRDYE 800
- APC and the like
- Heteroduplex analysis is then carried out by cleaving the heteroduplexes with an endonuclease under conditions and for a time sufficient to permit endonuclease cleavage at mismatches between wild-type and mutant.
- Cleavage products are physically separated by, for example, gel electrophoresis or other means which exploits a change in size or mass.
- Slab gel electrophoresis is well suited for large-scale mutation detection. The two-dimensional readout facilitates the detection of rare events, such as mutations, because a new band will stand out above the wild-type background and can be easily spotted.
- each new band is also obtained, an advantage over other methods based on detection of mismatches or conformational changes (Nataraj et al., Electrophoresis 20:1177-1185 (1999)), which do not indicate where in the molecule a mutation resides.
- the separated cleavage fragments are differentially detected using methods suitable for the labels.
- IRDYE-labeled cleavage products separated in a polyacrylamide gel are detected by the measuring the absorbance at each wavelength characteristic of the label used, i.e., 700 or 800 nm, as the fragments pass through a detector.
- Images of the gel are obtained by for example, direct scanning or photography followed by scanning and the images are visually analyzed using graphic display software, such as Adobe PHOTOSHOP (Adobe, San Jose, CA), QUICKTIME (Apple Computer, Cupertino, CA), NETSCAPE NAVIGATOR (Netscape, Mountain View, CA), or the like.
- the images are analyzed with the aid of a standard commercial image processing program to identify the presence of change in fragment size indicating cleavage by the endonuclease at a mutation induced mismatch which give information on the presence of a mutation as well as its location.
- mutations detected in a pool can be further investigated by screening the individual DNAs in the positive pools to identify the individual, e.g., plant, harboring the mutation. This rapid screening procedure determines the location of a mutation, or to within a few base pairs, for a PCR product up to 1 kb in size.
- Differential double-end labeling of amplification products allows for rapid visual confirmation, because mutations are detected on complementary strands, and so can be easily distinguished from amplification artifacts.
- An additional important advantage of double end-labeling for detecting both cleavage products is avoidance of false positive bands.
- False positive bands which might result from the practice of the disclosed methods are of two types: those that appear in multiple lanes for a single detected label and those that appear in a single lane but in the same position for both detected labels.
- IRDYE detection is carried out by viewing the gel in each of two channels which detect a different infrared (IRDYE) label. Because it is highly unlikely that the same mutation will appear in two different individuals, it is assumed that certain homoduplex sites are especially sensitive to variability in endonuclease digestion, causing bands to appear in multiple lanes above the background pattern.
- PCR product yield was determined to typically provide a low and inconsistent signal using both IR Dye 700 and IR Dye 800 dyes on opposing primers; however, consistent results have been obtained using a mixture of IRDye-labeled and unlabeled primers.
- DNA molecules within mixtures are improved using capillary technology.
- capillary electrophoresis has been successfully exploited for high throughput DNA sequencing (Kheterpal et al., Anal. Chem. 71:31A-37A (1999)) and for rapid heteroduplex (CDCE) and SSCP detection applications (Larsen et al., Hum. Mutat. 13:318-327 (1999); Li-Sucholeiki et al., Electrophoresis 20:1224-1232 (1999); Nataraj et al., Electrophoresis 20: 1177-1185 (1999)). It is expected that dHPLC will also be accelerated by the development of capillary columns.
- TILLING minimizes the effort required to find mutations
- ascertainment of a resulting phenotype requires additional characterization.
- Chemical mutagenesis introduces background mutations that can make phenotypic analysis uncertain, and multiple generations of outcrossing may be desirable.
- a rapid strategy is available if two independent severe lesions are found. Briefly, the two individuals can be crossed and their progeny typed. A phenotype attributable to the two non-complementing mutations will be found in every individual carrying both lesions, whereas non-complementing background mutations will sort independently.
- missense mutations should be identified as a by-product of screening for two severe lesions. Because it is estimated that 5-10% of EMS-induced mutations are temperature-sensitive (Ashburner, Drosophila, A Laboratory Handbook, Cold Spring Harbor Press, Cold Spring Harbor (1990)), the method of the present invention is likely to provide conditional mutants that can be used for epistasis and interaction analyses. Furthermore, by choosing evolutionarily conserved regions of proteins for TILLING, the probability of obtaining severe and conditional lesions is not only increased, but also mutations are provided in regions that are most useful for protein structure and function studies. The "Blocks" system, for example, is designed to find conserved regions amenable to the methods provided herein (Henikoff et al., Nucl. Acids Res. 27:226-228 (1999)).
- TILLING can be performed at a genomic scale to provide gene knockouts and conditional mutations for general study. For example, a collection of approximately 10,000 mutagenized reference M2 plants in an Arabidopsis race that is most suitable for TILLING has been partially established.
- the Columbia ecotype is a particularly suitable choice because it has been used for sequencing and EST analyses.
- Columbia erecta a Columbia derivative that carries an induced erecta allele so that it has favorable compact growth characteristics (Yokoyama et al., Plant J. 15:301-3 10 (1998)) has been used to establish the library.
- This line has been back-crossed to wild- type Columbia three times and self fertilized subsequent to EMS-mutagenesis, and so it is expected to be homozygous for about 90% of its genome. There should be only about 20 heterozygous mutations in the genome which could complicate the screening method described herein. However, even these heterozygotes can be eliminated by prescreening the unmutagenized parental genome.
- Columbia erecta seeds are being mutagenized with EMS using the same protocol as described herein for plants.
- each reference plant of the M2 generation can be grown from a separate Ml plant. It is important that DNA samples from different plants are nearly identical in concentration in order to maximize sensitivity to a mutation in any one sample plant.
- CMT2 and CMT3 Two Arabidopsis chromomethylase genes (CMT2 and CMT3) related to CMT1 were selected. Primers were chosen based primarily on the probability of introducing a severe lesion. Mutations in the CMT2 and CMT3 genes were detected with denaturing HPLC (dHPLC), followed by sequencing to determine the mutation. Additionally, in another embodiment TILLING was used to examine functional mutations in a gene of known sequence in Drosophila. Within another embodiment, two Arabidopsis genes, hdal and Sir2B were selected and subjected to high-throughput TILLING. Primers were selected to flank the gene region of interest and to a specific Tm to facilitate amplification.
- dHPLC denaturing HPLC
- genes of known sequence can be chosen for TILLING using methods for analyzing the DNA sequence for regions which would have a high probability for mutation depending on the mutagen used. By assigning a score to defined regions of a target gene based on the likelihood of obtaining a desirable mutation, genes can be placed in a rank order. The ranks can be used both to pick regions of the selected gene for primers and to choose the order in which genes will be TLLLed. Preliminary data with Arabidopsis suggests that approximately 5-10,000 reference plants will suffice for obtaining the desired mutations from just a single primer pair per gene that encompasses the most favorable region for TILLING. A computer program for choosing primers can output a list for oligonucleotide synthesis.
- Plants are especially well suited to the methods of the present invention, because they can be self-fertilized and seeds can be easily stored.
- Arabidopsis thaliana which has been described herein as a specific example of high throughput TILLING
- other crop plants can also benefit from TILLING.
- the same genes discovered in Arabidopsis can be studied in crop plants as listed above.
- genes in other plants which are the same or similar to those discovered in Arabidopsis can be selected.
- the identification of a similar gene can be accomplished, for example, using CODEHOP PCR primer design (Rose et al., Nucl. Acids Res. 26:1628-1635 (1998)). This is a PCR primer design method for amplification of distantly related sequences.
- each database entry can be, for example, a FASTA-formatted sequence, containing the mutation that was determined from the individual plant PCR products. Searching the TILLING database of mutant sequences (typically supplemented with a database providing a set of non-mutant controls) will return single entries for each mutation aligned with the query. The mutation itself can be easily pinpointed as (presumably) the only non-matching alignment pair.
- a user would search an amino acid sequence database to find an amino acid mutation or a nucleotide sequence database to identify a base mismatch. Each mutation can be confirmed by sequencing both strands. Confirmation of a heterozygous mutation by sequencing can be challenging even when both strands have been sequenced, however, computational methods exist for interpreting sequence trace data to identify heterozygous mutations.
- reverse genetics methods may have been an impediment to organizing genomics of some plant species, and the methods of the present invention will likely spur genomics in neglected but important plants. Further, the generality of TILLING means that screening for mutations by these methods is applicable to animals.
- reverse genetic techniques in zebrafish are both labor and resource intensive and are not suitable for genome-scale analysis.
- Other potentially suitable systems include cultured cells, for example, mutagenized mouse embryonic stem cells, which can be stored frozen and implanted when needed to obtain mice for phenotypic analysis.
- chromomethylase a DNA methyltransferase homologue with a chromodomain
- chromomethylase a DNA methyltransferase homologue with a chromodomain
- CMTl is found to be homozygous null. This non-essentiality of CMTl could be explained as redundant function if other chromomethylases exist in Arabidopsis.
- CODEHOP PCR primer design method Rose et al., Nucleic Acids Res. 26: 1628-1635 (1998) was employed and two different nucleic acid sequences evidently related to CMTl from A. thaliana genomic DNA were isolated. Using these PCR products to probe an A. thaliana genomic library, two new chromomethylase genes were identified, CMT2 and CMT3.
- RT-PCR and isolation and sequencing of the full coding regions of CMT2 and CMT3 cDNAs revealed that their intron/exon boundaries are similar to those of CMTl (Fig. 1).
- Quantitative RT-PCR expression studies showed that CMT2 and CMT3 are ubiquitously expressed at moderate levels, as might be expected for genes involved in silencing.
- Arabidopsis thaliana has been mutagenized with ethyl methanesulfonate (EMS) and the chromomethylase 2 (CMT2) and chromomethylase 3 (CMT3) genes have been examined for mutations.
- EMS ethyl methanesulfonate
- CMT2 chromomethylase 2
- CMT3 chromomethylase 3
- the two PCR products were TA-cloned (Invitrogen) and sequenced. Two unique sequences related to CMTl were identified and used to probe an A. thaliana genomic library (Clontech). The cDNA sample preparation and RT-PCR conditions used were previously described (Henikoff et al., Genetics 149:307-318 (1998)).
- EMS mutagenesis tissue collection and DNA extraction. Seeds from A. thaliana ecotype No-0 were mutagenized with 20 mM EMS for 18 hours (Koornneef et al., Mutat. Res. 93:109-123 (1982)). Seeds from these Ml plants were collected in batch for the M2 generation.
- Leaf samples from five M2 individuals were pooled prior to DNA extraction. To ensure that approximately equal amounts of tissue were collected from every individual, leaf samples were collected as punches using a #4 (9.5 mm diameter) cork borer and stored at -80°C. A modification of a quick DNA preparation protocol (Edwards et al, Nucleic Acids Res. 19:1349 (1991)) was used. DNAs from individual plants were prepared when a pool containing a mutation was identified.
- Samples for mutational screening and sequencing were generated in 20 ⁇ l reaction volumes containing approximately 1 ng pooled genomic DNA, 2.5 mM MgCl 2 , 100 ⁇ M dNTPs, 0.2 ⁇ M of forward and reverse primers, IX Pfu buffer and 2.5 U of Pfu polymerase (Stratagene). TOUCHDOWN PCR amplifications were performed as recommended by the manufacturer (Transgenomic Inc., San Jose, CA) (Kuklin et al., Genetic Testing 1 :201-206 (1997)). Cycle sequencing protocols were used with ABI Model 373 sequencers.
- Mutation detection was performed using the WAVE system (Transgenomic Inc., San Jose, CA). Following PCR amplification, the Pfu polymerase was inactivated while the DNA samples were heated and cooled to form heteroduplexes. For most fragments, the predicted WAVE (v.3.5) melting temperatures and separation gradients were used (Jones et al., Clin. Chem. 45:1133-1140 (1999)). For CMT2B and CMT3B, the software predicted two melting domains, and so the corresponding samples were analyzed at each of the predicted melting temperatures. After EMS mutagenesis (Redei et al., in, Methods in Arabidopsis Research, pp. 16-82.
- Base changes were detectable as extra peaks owing to melting of duplex regions around mismatches and reduced retention on the heated reverse phase HPLC column.
- DNAs from individual plants were amplified and typed, and the PCR sample carrying the alteration was sequenced using an amplification primer.
- nonsense mutations result from single base changes that convert an amino acid codon into a stop codon.
- missense mutations result when single base changes alter the amino acid encoded by a particular codon; these can be further categorized as those resulting in conservative and nonconservative substitutions.
- silent mutations result when a single base change to a codon does not alter the encoded amino acid. These changes are usually, but not exclusively, the result of mutations that alter the third base of a codon. Because nonsense and missense mutations that result in nonconservative substitutions are most likely to result in deleterious mutations, it is important to know the expected frequency of each class of mutation.
- EMS produces primarily C to T changes resulting in C/G to T/A transition mutations.
- LEAFY EMS-generated alleles http:// www.salk.edu/LABS/pbio-w/lfyseq.html
- 20/23 are C/G to T/A
- 2/23 are C/G to A/T
- 1/23 is A T to T/A.
- all changes are C/G to T/A transitions and using the standard Arabidopsis codon usage table (http://www.kazusa.
- coding regions that are evolutionarily highly conserved, the likelihood of recovering missense mutations with detrimental effects on gene function can be maximized.
- transition mutations in splice junctions are deleterious, and so for every intron in a chosen region there are at least two positions at which C/G to T/A mutations lead to loss of gene product. It can be calculated that overall 1% of the mutations in coding regions will be disruptions of splice junctions.
- a screen for mutations in a cell of interest demonstrated as an example the methods of the present invention analysis of the CMT2 and CMT3 using 835 M2 plants.
- transition mutations in splice junctions are deleterious, and so for every intron in a chosen region there are at least two positions at which C/G to T/A mutations lead to loss of gene product. It can be calculated that overall 1% of the mutations in coding regions will be disruptions of splice junctions.
- a screen for mutations in a cell of interest demonstrated as an example the methods of the present invention analysis of the CMT2 and CMT3 using 835 M2 plants. Seven different PCR fragments ranging in size from 345-970 bp were examined, for a total of approximately 2 Mb of DNA sequence screened by dHPLC. Thirteen chromatographic alterations were detected and confirmed to be mutations by amplification of multiple samples (Table 1); no PCR errors were found. Analysis of the isolated DNA demonstrated an error rate of ⁇ 10 "6 . All detected mutations were base transitions in either homozygotes or heterozygotes, as expected for EMS-mutagenized M2 plants.
- CMT2 In CMT2, one mutation resulted in an Asp to Asn amino acid change and another was detected within an intron.
- Two different changes in nucleotide sequence were identified in CMT3.
- One mutation changed a Glu codon to Lys, and the other changed a CAG Glu codon to a TAG stop codon.
- the stop codon resulted in truncation of CMT3 (Fig. 4), which lacked four conserved blocks that are known to be crucial for enzymatic function (Posfai et al., Nucleic Acids Res. 17:2421-2435 (1989)). Transition mutations were discovered in nine other plants, but each of these is identical to one of the mutations described above.
- This example provides a method for the examination of functional mutations in a gene of known sequence in fruit flies.
- Male flies will be fed EMS to induce point mutation in the genome.
- the males will be crossed enmass to Balancer 4* (Bal + ) females (where the balancer chromosome is used to suppress recombination and maintain heterozygous lines).
- Bal/ x Bal/ wherein * means mutagenized chromosome matings are set up, removing the parent flies after a sufficient egg-laying period.
- the number of males and females collected in each vial from the mating will depend on the sensitivity of the method of detection and the dose of mutagen used. It is expected that about 10 females and 10 males would result in about 10 * genomes represented among the resulting brood.
- Matings for the M2 will be carried out selecting about 20 aged non-Bal ( / ) and allowing egg laying.
- the vial will contain a sampling of mutagenized genomes and Bal chromosomes. Flies in the vial will be allowed to develop at low temperature (about 14°C) to hold the M3 generation as long as possible.
- DNA will be prepared from the / M2 parents in 8 x 12 arrays. It is expected that each independently mutagenized chromosome might be as rare as 1/40, and would presumably be missed. However, the representation of the average chromosome should be 1/10. Therefore, about half of the mutations will be detected on average, depending on the fragment size for screening.
- This Example describes a high-throughput TILLING method which was used to analyze the Arabidopsis hdal gene.
- a region of interest was amplified using a "left" primer labeled with a first label and a "right” primer labeled with a second label and wherein the labels are independently detectable.
- Heteroduplexes of the amplified and labeled DNA was nicked at a mismatch with the endonuclease CEL I.
- the use of label at both ends of the amplification products permitted identification of mutations and sequencing at single base resolution from no farther than the middle of any fragment, thus allowing for larger segments of a gene to be analyzed.
- Genomic DNA from each M2 plant was prepared from 0.2 g of leaf and/or stem tissue using the BIO101 FASTDNA system (Qbiogene, Carlsbad, CA) following the manufacturer's instructions. Concentrations of the DNA preparations were estimated by visualization on 1% agarose electrophoretic gels and were equalized prior to dilution (in 10 mM Tris pH 8.0, 1 mM EDTA) and pooling. The genomic DNA samples from each individual plant were pooled at either 5-fold or 8-fold representing either 5- or 8- individual plants per well, and the pools were arrayed on microtiter plates.
- genomic DNA pools were subjected to hdal gene-specific amplification using polymerase chain reaction (PCR) using primers designed with melting temperatures of 60°-70°C, and final annealing temperatures of T m -5°C were chosen. Briefly, each PCR amplification reaction was performed in 10 ⁇ L volumes using EXTAQ polymerase (PanVera Corporation, Madison, WI) using the manufacturer's protocol with the exception that only half the manufacturer's recommended concentration of buffer was used, and MgCl 2 concentration was increased to 2 mM.
- PCR polymerase chain reaction
- Primers (forward primer: 5' GGTAATGGATACTGGCGGCAATTCG 3' (SEQ ID NO: 9), reverse primer: 5' ACCACCCAAGAGCAGTAGGGGAACA 3'; SEQ ID NO: 10) were obtained from MWG Biotech (MWG Biotech Inc., High Point, NC).
- the forward primer was labeled with the infrared detectable label IRDYE 700 (IRDYE 700 (LI-COR Inc., Lincoln, NE), molecular formula: C 52 H6 7 N 4 O 5 PS) and the reverse primer was labeled with the infrared red detectable label IRDYE 800 (IRDYE 800 (LI-COR Inc.), molecular formula: C 5 H 75 N 4 O 6 PS).
- the primers were mixed in a ratio of 3 :2 labeled to unlabeled primer (IRDYE 700-labeled primer) and 4:1 labeled to unlabeled primer (IRDYE 800-labeled primer), for final primer concentrations of 0.2 ⁇ M.
- the reaction mixtures were subjected to amplification cycles in a MWG
- Biotech 96-well cycler (MWG Biotech Inc.) as follows: 1) 95°C for 2 min; 2) 8 cycles of TOUCHDOWN PCR: 94°C for 20 sec (denaturation), T m + 3°cto T m - 4°C decrementing 1°C per cycle (annealing), 72°C for 45 sec to 1 min (extension for 600 to 1000 bp products); 3) 45 cycles of: 94°C for 20 sec (denaturation), T m - 5°C (annealing), 72°C for 45 sec to 1 min; 4) 72°C for 5 min; 5) 99°C for 10 min (inactivation); 6) 70 cycles of 20 sec at 70°C to 49°C, decrementing 0.3 C per cycle (reannealing).
- the CEL I enzyme an endonuclease that preferentially cleaves mismatches in heteroduplexes between wildtype and mutant, was purified from 30 kg of celery essentially as described by Oleykowski et al. (Nucleic Acids Res.
- Amplification products were incubated with CEL I and cleavage products were then electrophoresed using an automated sequencing gel apparatus, and gel images are analyzed with the aid of a standard commercial image processing program. Briefly, 10 ⁇ l of each amplification product was mixed with 20 ⁇ l of CEL I buffer (lOmM Hepes pH 7.5, 10 mM MgSO 4 , 0.002% Triton-X-100, 20 ng/ml of bovine serum albumin) and
- MWG 96-well catch plates (MWG Biotech Inc.) were prepared by transferring about 1 to about 1.5 ⁇ l formamide load solution (1 mM EDTA pH 8 and 200 ⁇ g/ml bromphenol blue in deionized formamide) into each well of a fresh MWG 96-well catch plates (labeled and oriented).
- the reactions were subjected to denaturing gel electrophoresis by first transferring the reactions to a membrane comb using a comb-loading robot and the COMBLOAD program supplied by the manufacturer (MWG Biotech).
- An IRDYE 800- labeled 50-700 bp molecular weight marker mix (LI-COR Inc.) was applied to outside teeth.
- LI-COR Inc. LI-COR Global IR gel scanner
- the comb containing the CEL I-treated amplification products was inserted into a well on top of a 6.5 % acrylamide gel, electrophoresed for 1 min and removed. Electrophoresis was continued for 4 hours at 1500 V, 40 W, 40 mA limits at 50°C.
- the DNAs were detected in two separate channels by a LI-COR scanner as generally described by Middendorf et al. (Electrophoresis 13: 487-494 (1992); incorporated by reference herein in its entirely). As described in more detail below, this method was sufficiently sensitive to detect the approximately 100 atamole of cleavage product generated by CEL I in an 8-fold pool, or one in 16 genomes for a heterozygous mutation.
- the opposed PCR primers carried different dye labels. As there is no detectable overlap between the IRDYE 700 and IRDYE 800 dye labels, images were examined directly for the presence of novel bands in either channel, 700nm or 800nm wavelengths of excitation.
- the image files were visually analyzed using a graphics display software program such as Adobe Photoshop (Adobe, Inc., San Jose, CA).
- the images resulting from the gel scans showed a sequence-specific pattern of background bands resulting from endonucleolytic cleavages common to all 96 lanes.
- images representing both channels and switching between them lanes containing a novel band in one channel and a corresponding novel band in the other channel were identified.
- the sum of the two band sizes was equal to the full-length product visible at the top of the image.
- This visual assay was aided by the approximate proportionality of the migration distance to molecular weight, so that a band in one channel was nearly the same distance from the leading edge as the corresponding band in the other channel was from the full-length product.
- Image manipulation tools, rulers and guides were used for the determination of migration distances and lane numbers for the two bands.
- the individual DNA samples were similarly screened to identify the plant carrying the mutation. This rapid screening procedure determined the location of a mutation or within a few base pairs for PCR products up to 1 kb in size. Moreover, the combination of Cell and EMS induced mutagenesis permits one to simultaneously identify and localize the mutation. Because EMS causes specific transition mutations, the use of this method permits one to determine the sequence of the mutation upon examination of the reference sequence, the wild-type sequence of the mutation and this is true of other mutagens as well. Briefly, the individual DNA samples comprising the pool containing an identified mutation were screened.
- This screen resulted in the identification of the plant in which a point mutation had occurred and an estimated location within a few base pairs of the lesion as well as confirming the original detection event in the 8-fold pool screen.
- Each mutation found in the arrayed plates of individual genomic DNA was re-confirmed by DNA sequencing.
- This method provides for screening and identifying the plants which harbor detected mutations. But the method also provides, based on the size of the DNA fragments obtained on separation, i.e., gel electrophoresis, the location of the mutation.
- the skilled artisan can determine which of the detected mutations lies in a region of interest, i.e., mutations in regions that are most likely to have a biologically functional effect, and eliminate those in other regions, such as intron and regions of low protein sequence conservation. The elimination of the need to examine all mutations in these regions saves time and allows the artisan to focus efforts on the regions of biological interest. Additionally, with the precise location of a mutation and the use of a specific mutagen, the sequence , or identity , of the mutation can be known.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Cette invention concerne une stratégie génétique inverse simple et générale à utiliser dans des organismes pour lesquels des outils génétiques bien développés font défaut. Ce procédé consiste en particulier à mettre un organisme ou une cellule en contact avec un mutagène qui induit principalement des mutations ponctuelles dans l'ADN génomique; à préparer un ADN à partir de cet organisme ou de cette cellule; à amplifier une région génomique d'intérêt; et à déterminer les modifications se produisant dans la séquence d'ADN mutagénisée dans la région génomique d'intérêt, par rapport à l'organisme ou la cellule parent. La détermination des mutations peut consister à détecter les hétéroduplex en vue d'identifier un organisme ou une cellule mutant. Ces procédés servent en particulier à identifier des mutations fonctionnelles dans des plantes.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001253063A AU2001253063A1 (en) | 2000-03-31 | 2001-03-30 | Reverse genetic strategy for identifying functional mutations in genes of known sequence |
US10/240,456 US20040053236A1 (en) | 2001-03-30 | 2001-03-30 | Reverse genetic strategy for identifying functional mutations in genes of known sequences |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19379400P | 2000-03-31 | 2000-03-31 | |
US60/193,794 | 2000-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001075167A1 true WO2001075167A1 (fr) | 2001-10-11 |
Family
ID=22715029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/010545 WO2001075167A1 (fr) | 2000-03-31 | 2001-03-30 | Strategie genetique inverse pour identifier des mutations fonctionnelles dans des genes de sequence connue |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001253063A1 (fr) |
WO (1) | WO2001075167A1 (fr) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003008589A1 (fr) * | 2001-07-18 | 2003-01-30 | Asahi Kasei Kabushiki Kaisha | Elk1 gene associe a la phosphorylation |
US7354715B2 (en) | 2003-05-22 | 2008-04-08 | Dow Agrosciences Llc | High-throughput methods of screening DNA for deletions and other mutations |
US7393996B2 (en) * | 2002-10-22 | 2008-07-01 | Arcadia Biosciences Inc. | Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene |
EP1708559A4 (fr) * | 2003-12-03 | 2010-01-06 | Arcadia Biosciences Inc | Ble comprenant une proteine cireuse reduite du fait d'alterations non transgeniques d'un gene cireux |
US7786349B2 (en) | 2003-04-09 | 2010-08-31 | Bayer Bioscience N.V. | Methods and means for increasing the tolerance of plants to stress conditions |
WO2012004013A2 (fr) | 2010-07-08 | 2012-01-12 | Bayer Bioscience N.V. | Protéine transportrice de glucosinolate et ses utilisations |
US9062348B1 (en) | 2005-12-22 | 2015-06-23 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
US9376719B2 (en) | 2005-09-29 | 2016-06-28 | Keygene N.V. | High throughput screening of mutagenized populations |
US9898576B2 (en) | 2005-06-23 | 2018-02-20 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
US10023907B2 (en) | 2006-04-04 | 2018-07-17 | Keygene N.V. | High throughput detection of molecular markers based on AFLP and high through-put sequencing |
US10316364B2 (en) | 2005-09-29 | 2019-06-11 | Keygene N.V. | Method for identifying the source of an amplicon |
WO2020185663A3 (fr) * | 2019-03-08 | 2020-10-22 | Board Of Trustees Of Michigan State University | Maîtriser l'auto-incompatibilité chez les plantes diploïdes pour la sélection et la production d'hybrides par la modulation du ht |
WO2021069614A1 (fr) * | 2019-10-10 | 2021-04-15 | Carlsberg A/S | Procédés de préparation de compositions de plantes mutantes |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824471A (en) * | 1995-06-05 | 1998-10-20 | Brigham And Women's Hospital | Detection of mismatches by cleavage of nucleic acid heteroduplexes |
US5869245A (en) * | 1996-06-05 | 1999-02-09 | Fox Chase Cancer Center | Mismatch endonuclease and its use in identifying mutations in targeted polynucleotide strands |
US5922535A (en) * | 1995-11-07 | 1999-07-13 | Huo; Li | Identifying sequence differences in nucleic acid populations |
US5958692A (en) * | 1994-04-25 | 1999-09-28 | Variagenics, Inc. | Detection of mutation by resolvase cleavage |
US6015670A (en) * | 1996-05-17 | 2000-01-18 | Hexagen Technology Limited | Methods for identifying a mutation in a gene of interest without a phenotypic guide using ES cells |
-
2001
- 2001-03-30 WO PCT/US2001/010545 patent/WO2001075167A1/fr active Search and Examination
- 2001-03-30 AU AU2001253063A patent/AU2001253063A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5958692A (en) * | 1994-04-25 | 1999-09-28 | Variagenics, Inc. | Detection of mutation by resolvase cleavage |
US5824471A (en) * | 1995-06-05 | 1998-10-20 | Brigham And Women's Hospital | Detection of mismatches by cleavage of nucleic acid heteroduplexes |
US5922535A (en) * | 1995-11-07 | 1999-07-13 | Huo; Li | Identifying sequence differences in nucleic acid populations |
US6015670A (en) * | 1996-05-17 | 2000-01-18 | Hexagen Technology Limited | Methods for identifying a mutation in a gene of interest without a phenotypic guide using ES cells |
US5869245A (en) * | 1996-06-05 | 1999-02-09 | Fox Chase Cancer Center | Mismatch endonuclease and its use in identifying mutations in targeted polynucleotide strands |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003008589A1 (fr) * | 2001-07-18 | 2003-01-30 | Asahi Kasei Kabushiki Kaisha | Elk1 gene associe a la phosphorylation |
US7393996B2 (en) * | 2002-10-22 | 2008-07-01 | Arcadia Biosciences Inc. | Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene |
US7928298B2 (en) | 2002-10-22 | 2011-04-19 | Arcadia Biosciences, Inc. | Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene |
US7786349B2 (en) | 2003-04-09 | 2010-08-31 | Bayer Bioscience N.V. | Methods and means for increasing the tolerance of plants to stress conditions |
US7354715B2 (en) | 2003-05-22 | 2008-04-08 | Dow Agrosciences Llc | High-throughput methods of screening DNA for deletions and other mutations |
US8735649B2 (en) | 2003-12-03 | 2014-05-27 | Arcadia Biosciences, Inc. | Wheat having reduced waxy protein due to non-transgenic alterations of a waxy gene |
EP1708559A4 (fr) * | 2003-12-03 | 2010-01-06 | Arcadia Biosciences Inc | Ble comprenant une proteine cireuse reduite du fait d'alterations non transgeniques d'un gene cireux |
US10978175B2 (en) | 2005-06-23 | 2021-04-13 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
US9898576B2 (en) | 2005-06-23 | 2018-02-20 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
US10235494B2 (en) | 2005-06-23 | 2019-03-19 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
US10095832B2 (en) | 2005-06-23 | 2018-10-09 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
US9898577B2 (en) | 2005-06-23 | 2018-02-20 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
US9896721B2 (en) | 2005-06-23 | 2018-02-20 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
US10538806B2 (en) | 2005-09-29 | 2020-01-21 | Keygene N.V. | High throughput screening of populations carrying naturally occurring mutations |
US10316364B2 (en) | 2005-09-29 | 2019-06-11 | Keygene N.V. | Method for identifying the source of an amplicon |
US9670542B2 (en) | 2005-09-29 | 2017-06-06 | Keygene N.V. | High throughput screening of populations carrying naturally occurring mutations |
US9657335B2 (en) | 2005-09-29 | 2017-05-23 | Keygene N.V. | High throughput screening of populations carrying naturally occurring mutations |
US9574230B2 (en) | 2005-09-29 | 2017-02-21 | Keygene N.V. | High throughput screening of populations carrying naturally occuring mutations |
US11649494B2 (en) | 2005-09-29 | 2023-05-16 | Keygene N.V. | High throughput screening of populations carrying naturally occurring mutations |
US9376719B2 (en) | 2005-09-29 | 2016-06-28 | Keygene N.V. | High throughput screening of mutagenized populations |
US9745627B2 (en) | 2005-09-29 | 2017-08-29 | Keygene N.V. | High throughput screening of populations carrying naturally occurring mutations |
US10233494B2 (en) | 2005-09-29 | 2019-03-19 | Keygene N.V. | High throughput screening of populations carrying naturally occurring mutations |
US9062348B1 (en) | 2005-12-22 | 2015-06-23 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
US9334536B2 (en) | 2005-12-22 | 2016-05-10 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
US10106850B2 (en) | 2005-12-22 | 2018-10-23 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
US11008615B2 (en) | 2005-12-22 | 2021-05-18 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
US10023907B2 (en) | 2006-04-04 | 2018-07-17 | Keygene N.V. | High throughput detection of molecular markers based on AFLP and high through-put sequencing |
WO2012004013A2 (fr) | 2010-07-08 | 2012-01-12 | Bayer Bioscience N.V. | Protéine transportrice de glucosinolate et ses utilisations |
WO2020185663A3 (fr) * | 2019-03-08 | 2020-10-22 | Board Of Trustees Of Michigan State University | Maîtriser l'auto-incompatibilité chez les plantes diploïdes pour la sélection et la production d'hybrides par la modulation du ht |
WO2021069614A1 (fr) * | 2019-10-10 | 2021-04-15 | Carlsberg A/S | Procédés de préparation de compositions de plantes mutantes |
CN114786473A (zh) * | 2019-10-10 | 2022-07-22 | 嘉士伯有限公司 | 制备突变植物的方法 |
CN114786473B (zh) * | 2019-10-10 | 2023-12-19 | 嘉士伯有限公司 | 制备突变植物的方法 |
US12185681B2 (en) | 2019-10-10 | 2025-01-07 | Carlsberg A/S | Methods for preparing mutant plants |
JP7667145B2 (ja) | 2019-10-10 | 2025-04-22 | カールスバーグ アグシャセルスガーブ | 変異体植物の調製方法 |
Also Published As
Publication number | Publication date |
---|---|
AU2001253063A1 (en) | 2001-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040053236A1 (en) | Reverse genetic strategy for identifying functional mutations in genes of known sequences | |
Taheri et al. | TILLING, high-resolution melting (HRM), and next-generation sequencing (NGS) techniques in plant mutation breeding | |
Till et al. | Discovery of chemically induced mutations in rice by TILLING | |
Arbelaez et al. | 1k-RiCA (1K-Rice Custom Amplicon) a novel genotyping amplicon-based SNP assay for genetics and breeding applications in rice | |
Gady et al. | Implementation of two high through-put techniques in a novel application: detecting point mutations in large EMS mutated plant populations | |
Suzuki et al. | MNU-induced mutant pools and high performance TILLING enable finding of any gene mutation in rice | |
Va et al. | Transposon display identifies individual transposable elements in high copy number lines | |
Le Signor et al. | Optimizing TILLING populations for reverse genetics in Medicago truncatula | |
Waugh et al. | Harvesting the potential of induced biological diversity | |
Slade et al. | TILLING moves beyond functional genomics into crop improvement | |
CA2132968A1 (fr) | Exploration des defauts de complementarite genomique | |
WO2001075167A1 (fr) | Strategie genetique inverse pour identifier des mutations fonctionnelles dans des genes de sequence connue | |
Wienholds et al. | Target-selected gene inactivation in zebrafish | |
AU779568B2 (en) | Genetically filtered shotgun sequencing of complex eukaryotic genomes | |
Liu et al. | Transposon mutagenesis and analysis of mutants in UniformMu maize (Zea mays) | |
Cooper et al. | TILLING and ecotilling for rice | |
Bahary et al. | The Zon laboratory guide to positional cloning in zebrafish | |
EP1001037A2 (fr) | Pre-selection et isolement d'un polymorphisme de mononucleotide | |
KR102461763B1 (ko) | 서양계 호박의 여교배 세대단축 육종을 위한 단일염기 다형성 마커세트 및 이의 용도 | |
US6773889B2 (en) | Method for detecting genomic destabilization arising during tissue culture of plant cells | |
Tagu et al. | Techniques for molecular biology | |
Goonetilleke et al. | Discovery of Quantitative Trait Loci for Nut and Quality Traits in Almond | |
US5013644A (en) | Identification of africanized honey bees | |
US20130004951A1 (en) | Bulked mutant analysis | |
Jacobson et al. | A Drosophila minisatellite contains multiple chi sequences |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10240456 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |